Search

Your search keyword '"Chilton, Robert"' showing total 582 results

Search Constraints

Start Over You searched for: Author "Chilton, Robert" Remove constraint Author: "Chilton, Robert"
582 results on '"Chilton, Robert"'

Search Results

2. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

6. Cardioprotective Potential of Sodium-Glucose Co-Transporter-2 Inhibitors in Cancer Patients Treated With Anthracyclines: An Observational Study

10. Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

11. Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects.

13. Current and Emerging Issues in the Management of Heart Failure in Primary Care

14. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

15. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

21. The OPTIFAST total and partial meal replacement programme reduces cardiometabolic risk in adults with obesity: Secondary and exploratory analysis of the OPTIWIN study.

29. Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes

30. Novel versus Conventional sequencing of Beta-blockers, SGLT2i’s, ARNI’s and MRAs in stable patients with HFrEF (NovCon sequencing study): Protocol for a 5-year pragmatic, real world, single-blinded, randomised controlled trial (Preprint)

31. Novel versus Conventional sequencing of Beta-blockers, SGLT2i’s, ARNI’s and MRAs in stable patients with HFrEF (NovCon sequencing study): protocol for a 5-year pragmatic, real world, open label, randomised clinical trial (Preprint)

34. Deciphering the connection: Diabetes, pericyte dysfunction, and their impact on cardiovascular health.

38. Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory Phenotype in Peripheral Blood Mononuclear Cells and Plasma of Type 2 Diabetes Subjects

44. Gene Regulatory Network Construction Based on a Particle Swarm Optimization of a Long Short-term Memory Network

49. Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes.

Catalog

Books, media, physical & digital resources